Zacks Investment Research
01 Oct 2026, 22:51 UTC · 18h ago
Verdict
Headline leans bullish. We score AMGN −0.30 across four claims.
Score contradicts the headline.
Leans bullish
From its wording — no explicit rating
−0.30moderately bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish · 1 new · 3 priced in
Amgen's shares closed at $407.27, a decrease of 3.38% in the latest trading session.
Newpublished Oct 01, 2026, refers to 'latest trading session'
So whatThe price drop follows a prior decline of 4.82%, suggesting a cumulative weekly slide of over 8%.
More negative than 78% of claims this week
The consensus EPS projection for the upcoming quarter is $5.69, a 0.89% increase year-over-year.
Continue reading
5 related stories
More negative than 67% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inconsensus estimate for upcoming disclosure
So whatWith growth limited to <1%, any slight miss in the next print could lead to a negative EPS surprise.
More positive than 44% of claims this week
Amgen's Forward P/E ratio is 18.38, which is a discount to the industry average of 22.46.
Priced incurrent valuation data
So whatThe stock trades at roughly 18% below its industry peers' multiple.
More positive than 44% of claims this week
The Zacks Consensus EPS estimate has moved 0.15% lower within the past month.
Priced intrend over the past month
More negative than 64% of claims this week
Which stocks this story touches
More negative than 67% of ticker scores this week
The stock experienced a significant daily price drop and underperformed the S&P 500.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
3h ago
−0.9%
Price agrees with the score
$403.45 vs $407.27 close before publication (Oct 1) · not market-adjusted
AMGN chart →
